ITGAL and glioblastoma: Similarly, integrins CD49a (ITGA1), CD49d (ITGA4), CD51 (ITGAV), and CD11a (ITGAL) were selected for further validation based on elevated gene expression in glioblastoma-infiltrating T cells.